Anesthesia management of CRS and HIPEC in advanced ovarian cancer with ultra-high intra-abdominal pressure: a case report

Anesthesia management of CRS and HIPEC in advanced ovarian cancer with ultra-high intra-abdominal pressure: a case report

Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is a leading treatment for advanced ovarian cancer, significantly improving overall survival and disease-free survival. This case involves a patient with peritoneal metastasis and ultra-high intra-abdominal p...

Full description

Saved in:
Bibliographic Details
Main Authors: Suli Chen, Yanjun Lin, Shuncai Gao, Shuo Liu, Zhanmin Yang, Ruiqing Ma, Liangyuan Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Oncology
Subjects:
ovarian cancer
cytoreductive surgery
hyperthermic intraperitoneal chemotherapy
intra-abdominal hypertension
anesthetic management
goal-directed fluid therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1449171/full
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is a leading treatment for advanced ovarian cancer, significantly improving overall survival and disease-free survival. This case involves a patient with peritoneal metastasis and ultra-high intra-abdominal pressure (36 mmHg). CRS + HIPEC induces extensive pathological and physiological changes affecting respiratory, circulatory, renal, coagulation, and metabolic systems. Effective perioperative anesthesia management, including the type and volume of fluids administered, is crucial for optimizing patient outcomes. The complexities of anesthesia management in such cases present significant challenges.
ISSN:2234-943X

Similar Items